HOME › DRUGS › SIMVASTATIN
ACTIVE SUBSTANCE / INN

SIMVASTATIN

Brand name(s): ZOCOR, FLOLIPID, JUVISYNC, SIMVASTATIN, VYTORIN, EZETIMIBE AND SIMVASTATIN
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA201890
ANDA077691
ACTIVE SUBSTANCE
Simvastatin
REGULATORS
FDA
SPONSORS / MAH
SALERNO PHARMS, TEVA PHARMS, SUN PHARM INDS LTD
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SIMVASTATINANDA076532TEVA PHARMSNone (Tentative Approval)
FLOLIPIDNDA206679SALERNO PHARMSPrescription
SIMVASTATINANDA076285SUN PHARM INDS LTDDiscontinued
SIMVASTATINANDA077691AUROBINDO PHARMAPrescription
EZETIMIBE AND SIMVASTATINANDA200082AUROBINDO PHARMA USAPrescription
EZETIMIBE AND SIMVASTATINANDA201890ANI PHARMSDiscontinued
JUVISYNCNDA202343MERCK SHARP DOHMEDiscontinued
ZOCORNDA019766ORGANONDiscontinued
ZOCORNDA019766ORGANONPrescription
VYTORINNDA021687ORGANONPrescription

FULL INTELLIGENCE ON SIMVASTATIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →